Please click here to check who's online and chat with them.

Find Verified Diagnostic Kits Suppliers, Manufacturers and Wholesalers

Jun-15-24
Supplier From India
Oct-22-20
Supplier From South Korea (Republic Of Korea)
Sep-09-09
Supplier From Foshan, Guangdong, China
Dec-20-21
Supplier From Delhi, DL, India
Nov-09-18
Supplier From Beijing, Beijing, China
5086 Diagnostic Kits Suppliers
Short on time? Let Diagnostic Kits sellers contact you.
Dec-29-20
Supplier From Motihari, Bihar, India
Nov-24-20
Supplier From China
Oct-23-20
Supplier From Wuhan, Hubei, China
Mar-02-22
Supplier From Antalya, Turkey
Jan-22-22
Supplier From Italy
Jan-05-22
Supplier From United States
Nov-11-21
Supplier From -Zhengzhou, Henan, China
Mar-04-21
Supplier From HangZhou, ZheJiang, China
Mar-06-21
Supplier From Braga, Portugal
Mar-03-21
Supplier From Lithuania
Dec-04-20
Supplier From United Kingdom
Jun-01-20
Supplier From Doral, FL, United States
Sep-05-19
Supplier From Toronto, ON, Canada
VERIFIED
Jun-01-21
Angiten-COVID-19 Virus Test Kit (Colloidal Gold)
Quantity of box: 25 persons/box
Brand: Easysweet
NMPA (National Medical Products Administration): Approved
CE: with CE mark
BfArM: listed
Test Method: Antigen Test
Result Time: 10-15 mins
Sample Type: Nasal Swab
Sensitivity: 96.70%
Specificity: 100%
Accuracy: 98.94%
Shelf Life: 24 months
Storage Temperature: 2-30 Degree Celsius
Country of Origin: Made in China
Additional Information:
Production Capacity: 1 million
Delivery Time: 10-15 days
Packaging Details: 25 tests in a pack, 40packs/ carton
Angiten-COVID-19 Virus Test Kit is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasopharyngeal swab specimens from individuals who meet COVID-19clinical and / or epidemiological criteria. It can be used by professional only.
VERIFIED
Nov-07-20
The COVID-19 IgG/IgM (Whole Blood/Serum/Plasma) Rapid Test Device utilizes lateral flow technology that is used for the qualitative, differential detection of both anti-SARS-CoV-2 IgM and IgG antibodies. In general, antibodies can be detected 1-3 weeks after infection. This test is intended to screen patients for COVID-19. Combining RNA and Antibody tests can significantly raise the sensitivity for detecting COVID-19 in infected individuals.

This test has been authorized by the FDA under a EUA for professional use CLIA and CLIA WAIVED for Point Of Care.
This test has been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens.

This product is intended for professional use and not for home use.

FACT SHEET FOR HEALTHCARE PROVIDERS

This test has been authorized by the FDA under a EUA for use by authorized CLIA laboratories. This device is CLIA waived for point of care use for fingerstick whole blood specimens only. The user should be trained in the procedure. Wear appropriate protective attire for your safety when handling patient samples.
This test has been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens.
There should be a blue line in the control region (next to ) before testing, discard the device if there is no blue line.
5086 Diagnostic Kits Suppliers
Short on time? Let Diagnostic Kits sellers contact you.